PENGU price is down 35% from its July peak, with rising volume and oversold signals hinting at a possible rebound as analyst eyes September upswing.PENGU price is down 35% from its July peak, with rising volume and oversold signals hinting at a possible rebound as analyst eyes September upswing.

PENGU price slides 35% from local top, analyst eyes next leg higher in September

PENGU price has fallen sharply from its late-July peak, yet analysts suggest the decline could set the stage for a stronger rebound in September.

Summary
  • PENGU trades at $0.027, down 35% from July’s local high.
  • NFT market slump and ETH pullback drove selling pressure.
  • Analysts see September catalysts as setup for a rebound.

The Pudgy Penguins (PENGU) token is trading at $0.027 as of press time, down roughly 35% from its July 28 local high of $0.043. After declining 13% over the past week and 20% over the past 30 days, the token is nearly 60% below its peak of $0.068 set in December 2024. 

Despite the price decline, trading activity is still strong. PENGU recorded $214.8 million in spot volume over the past 24 hours, up 15% from the day before. Derivatives data from Coinglass show futures turnover rising 24% to $586 million, while open interest dropped 5.3% to $275 million.

During a pullback, rising volume combined with declining open interest often shows that traders are closing positions rather than building new leverage, indicating cautious sentiment.

PENGU price market drivers and sentiment shift

PENGU’s drop is a reflection of the overall cooling of the NFT market, whose monthly volume dropped from a peak of $8.2 billion on Aug. 14 to $6 billion as of press time. Ethereum’s (ETH) price retreat also weighed on valuations despite positive ecosystem developments.

The transition of PENGU from an NFT-linked token to a utility-driven brand has been taking place. The launch of Pudgy Party, a Web3 mobile game on Aug. 29 that quickly surpassed 50,000 downloads and ranked in the top 10 of the App Store, introduced direct utility for the token through in-game purchases and staking rewards.

Short-term on-chain demand, including activity tied to Pudgy Penguins’ mobile game downloads, has not offset profit-taking and portfolio rebalancing by holders.

Still, analyst Ali Martinez suggested in a Sept. 1 post on X that the correction looks like a healthy pause before the next leg higher, pointing to September as a potential turning point for momentum.

PENGU price technical analysis

Chart indicators point to consolidation at current levels. The relative strength index, which is presently trading at about 41, a neutral zone just above oversold territory, suggests that there may be room for growth if buyers step in. The Williams %R has already entered deep oversold conditions, historically a reversal zone for PENGU.

PENGU price slides 35% from local top, analyst eyes next leg higher in September  - 1

Momentum and MACD levels remain negative, and most short- and mid-term moving averages are skewed downward, suggesting short-term bearish pressure. However, the 100-day and 200-day averages continue to be supportive and could sustain the longer-term trend.

If $0.027 continues to be a support base, the next upward target is near $0.032, which is consistent with the 20-day moving average. If current levels are not defended, there may be a retest of the $0.025 region.

Given that Q4 usually signifies periods of peak momentum and September is believed to be a historically active month for cryptocurrency markets, the token’s position around significant support levels may determine its next move.

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Edges higher ahead of BoC-Fed policy outcome

Edges higher ahead of BoC-Fed policy outcome

The post Edges higher ahead of BoC-Fed policy outcome appeared on BitcoinEthereumNews.com. USD/CAD gains marginally to near 1.3760 ahead of monetary policy announcements by the Fed and the BoC. Both the Fed and the BoC are expected to lower interest rates. USD/CAD forms a Head and Shoulder chart pattern. The USD/CAD pair ticks up to near 1.3760 during the late European session on Wednesday. The Loonie pair gains marginally ahead of monetary policy outcomes by the Bank of Canada (BoC) and the Federal Reserve (Fed) during New York trading hours. Both the BoC and the Fed are expected to cut interest rates amid mounting labor market conditions in their respective economies. Inflationary pressures in the Canadian economy have cooled down, emerging as another reason behind the BoC’s dovish expectations. However, the Fed is expected to start the monetary-easing campaign despite the United States (US) inflation remaining higher. Investors will closely monitor press conferences from both Fed Chair Jerome Powell and BoC Governor Tiff Macklem to get cues about whether there will be more interest rate cuts in the remainder of the year. According to analysts from Barclays, the Fed’s latest median projections for interest rates are likely to call for three interest rate cuts by 2025. Ahead of the Fed’s monetary policy, the US Dollar Index (DXY), which tracks the Greenback’s value against six major currencies, holds onto Tuesday’s losses near 96.60. USD/CAD forms a Head and Shoulder chart pattern, which indicates a bearish reversal. The neckline of the above-mentioned chart pattern is plotted near 1.3715. The near-term trend of the pair remains bearish as it stays below the 20-day Exponential Moving Average (EMA), which trades around 1.3800. The 14-day Relative Strength Index (RSI) slides to near 40.00. A fresh bearish momentum would emerge if the RSI falls below that level. Going forward, the asset could slide towards the round level of…
Share
BitcoinEthereumNews2025/09/18 01:23